REBECCA DURKIN: Open Payments
NPI 1053632737 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,523 in 73 payments from 14 companies in 2025. Trend: 2023 $519 · 2024 $1,267 · 2025 $1,523
Food & beverage: $1,523
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $361 |
| Axsome Therapeutics, Inc. | 13 | $307 |
| ABBVIE INC. | 12 | $221 |
| Corium, LLC | 8 | $157 |
| Neurocrine BioSciences, Inc. | 4 | $92 |
| Collegium Pharmaceutical, Inc. | 4 | $78 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| Lundbeck LLC | 2 | $46 |
| Alkermes, Inc. | 2 | $42 |
Products named: REXULTI, Auvelity, VRAYLAR, Azstarys, INGREZZA, Jornay PM, COBENFY, SPRAVATO.
Industry payments across IL — which companies pay providers there.
